Tag Archives: Paul Greengard

Pearl Meister Greengard Prize to be awarded to pioneering RNA researcher Joan Steitz

A prestigious Rockefeller University award for exceptional women scientists recognizes a pioneer in the field of RNA biology whose discoveries involved patients with a variety of autoimmune diseases. Steitz will receive the award from National Geographic Explorer in Residence Sylvia Earle at a ceremony in Rockefeller’s Caspary Auditorium on November 29. More »

Tags: , ,

2011 Pearl Meister Greengard Prize to be awarded to McGill University memory researcher

Brenda Milner, a pioneer in the field of cognitive neuroscience whose discoveries revolutionized the understanding of memory, will be awarded the 2011 Pearl Meister Greengard Prize from The Rockefeller University.
More »

Tags: ,

Anti-inflammatory drugs reduce effectiveness of SSRI antidepressants

Scientists have shown that anti-inflammatory drugs, which include ibuprofen, aspirin and naproxen, reduce the effectiveness of the most widely used class of antidepressant medications, the selective serotonin reuptake inhibitors, or SSRIs, often prescribed for depression and obsessive-compulsive and anxiety disorders. More »

Tags: , , ,

Molecule that spurs cell’s recycling center may help Alzheimer’s patients

A molecule that activates the cell’s natural recycling program may flush away the protein fragments that accumulate and form senile plaques in Alzheimer’s disease. New research suggests that stimulating this activity, either through drugs or natural processes, may improve the quality of life for people with diseases caused by built-up proteins in the brain. More »

Tags: , , , ,

2010 Pearl Meister Greengard Prize goes to two pioneers of cancer genetics

Janet Davison Rowley and Mary-Claire King, pioneering cancer geneticists, are the recipients of the 2010 Pearl Meister Greengard Prize awarded by The Rockefeller University. Established by Nobel Prize winner Paul Greengard and his wife, sculptor Ursula von Rydingsvard, the prize honors women who have made extraordinary contributions to biomedical science, a group that historically has not received appropriate recognition and acclaim. More »

Tags: , , ,

Paul Greengard receives Karolinska Institutet’s Bicentennial Gold Medal

The gold medal is the highest award conferred by the Karolinska Institutet, one of the world’s leading medical universities, during its 200th anniversary celebrations. The medal recognizes the work of an individual not permanently located at the Karolinska Institutet, who has contributed to and has achieved acknowledged eminence in the university’s activities. More »

Tags: , , ,

Scientists identify protein that spurs formation of Alzheimer’s plaques

Rockefeller researchers report that the cancer drug Gleevec reduces Alzheimer’s plaques in a mouse model of the disease by binding to a molecule called gamma-secretase activating protein, or GSAP. By knocking out the gene that produces GSAP, the researchers reduced the primary component of senile plaques. They say that the development of compounds that work like Gleevec and target GSAP could revolutionize the treatment of this disease. More »

Tags: , , ,

MicroRNAs play a role in cocaine addiction

MicroRNAs, short stretches of RNA that silence genes, have already been linked to cancer, heart disease and mental disorders such as schizophrenia. New research by Rockefeller University scientists suggests microRNAs are also involved in regulating the motivation to consume cocaine, a finding that could ultimately lead to new ways of combating addictive diseases in humans. More »

Tags: , , , ,

Alzheimer’s brain protein may provide target for treating mental retardation

Reducing the level of β-amyloid, a protein found in the brains of patients with Alzheimer’s disease and Down syndrome, may improve the cognitive abilities of children with Down syndrome. The new study by Rockefeller University scientists may provide a model for developing new anti-amyloid drugs. More »

Tags: , , , , ,

Scientists identify potential new target for schizophrenia drugs

A protein that boosts the signaling power of a receptor involved in relaying messages between brain cells may provide a new target for the development of treatments for schizophrenia and Parkinson’s disease. More »

Tags: , , , ,

Leslie Vosshall, Paul Greengard win Dart/NYU biotech awards

Rockefeller scientists receive honors for their contributions to next-generation insect repellents and drugs to treat neurological diseases. More »

Tags: , , , ,

Mouse model reveals a cause of ADHD

New research in a mouse model of attention deficit/hyperactivity disorder suggests that the root of the psychiatric disorder might be the over-activity of a protein that regulates the brain’s reward-motivation system. The work suggests a path toward new treatments for symptoms including inattentiveness, over-activity and impulsivity. More »

Tags: , , , ,

Loss of epigenetic regulators causes mental retardation

New findings, published in recent issues of Neuron and Science, indicate that malfunction of a protein complex that normally suppresses gene activation causes mental retardation in mice and humans and may even play a role in promoting susceptibility to drug addiction. More »

Tags: , , , ,

2009 Pearl Meister Greengard Prize goes to pioneering geneticist

The 2009 Pearl Meister Greengard Prize recognizes Suzanne Cory, a world-renowned geneticist and pioneering scientific leader. The first woman to serve as director of Australia’s prestigious Walter and Eliza Hall Institute, she has been an influential force in shaping science policy in her nation. More »

Tags: ,

Brain protein may be a target for fast-acting antidepressants

It takes weeks or months for the effect of most antidepressants to kick in, time that can feel like an eternity to those who need the drugs the most. But new research suggests that a protein called p11 may be the key to developing drugs that begin to work in as little as two days. More »

Tags: ,

Ritalin may cause changes in the brain’s reward areas

A common treatment for attention deficit/hyperactivity disorder, prescribed millions of times a year, may change the brain in the same ways that cocaine does, a new study in mice suggests. More »

Tags: , , ,

Breakthrough in cell-type analysis offers new way to study development and disease

It’s sometimes said that disease does not discriminate, but that’s not true. Many diseases are very particular about the types of cells they attack, laying waste to one population while sparing its nearly identical neighbors for no apparent reason. New research from The Rockefeller University for the first time enables scientists to carefully study the biomolecular differences among types of cells in order to learn what makes some susceptible to attack and others resistant. More »

Tags: , ,

For treating advanced Parkinson’s, new research points to serotonin

New evidence from a mouse model of Parkinson’s disease suggests for the first time that serotonin, a well-studied neurotransmitter involved in regulating mood, appetite, sexuality and sleep, also plays a crucial role in the world’s second most common brain disorder. More »

Tags: ,

Brain cells need microRNA to survive

New research from Rockefeller University shows that neurons that cannot produce microRNAs, tiny single strands of RNA that regulate the expression of genes, slowly die in a manner similar to what is seen in such human neurodegenerative disorders as Alzheimer’s and Parkinson’s diseases. More »

Tags: ,

Mice on Prozac help scientists find better depression treatments

By comparing mice that had been given Prozac with mice given an alternate drug, researchers have identified a new class of chemicals that could offer better control over serotonin and more effective treatments for the debilitating mental illness. More »

Tags: ,